Sanbo Neuroscience plans to participate in the investment to establish Tianjin Yuanming Haihe Brain Science Venture Capital Partnership
I'm PortAI, I can summarize articles.
Sanbo announced that it will participate as a limited partner in the establishment of Tianjin Yuanming Haihe Brain Science Venture Capital Partnership, planning to raise funds of 300 million yuan, with the company subscribing 57 million yuan of its own funds. This move aims to improve the industrial chain, enhance clinical diagnosis and treatment levels, and focus on investments in the field of brain science, particularly in the areas of brain disease examination, treatment, and health management, to strengthen the company's competitiveness
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments